Physician profile
Daniel B Oneill
NPI 1831282631
$6,658.94
in general payments reported to CMS, 2019-2025
31 companies · $1,125 in 2025
The $1,125 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $709 · 2021: $756 · 2022: $938 · 2023: $1,302 · 2024: $1,245 · 2025: $1,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,672.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,284.73 | 2019-2025 | Triathlon, Mako, Accolade |
| Catalyst Orthoscience | $557.70 | 2021-2022 | |
| Smith+Nephew, INC. | $546.36 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Firstpass |
| Medinc of Texas | $372.12 | 2022-2025 | |
| Fidia Pharma USA INC. | $299.68 | 2019-2024 | Triluron, Hymovis, Hyalgan |
| Pacira Therapeutics, INC. | $192.61 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $180.79 | 2024-2025 | |
| Horizon Therapeutics Plc | $134.07 | 2020 | |
| Heron Therapeutics, INC. | $95.93 | 2023-2024 | Zynrelef |
| Ermi LLC | $93.73 | 2019-2021 | |
| Abbvie INC. | $81.72 | 2023-2025 | |
| Maxx Orthopedics, INC. | $79.82 | 2022 | |
| Vericel Corporation | $76.10 | 2020-2025 | Maci |
| Zimmer Biomet Holdings, INC. | $75.99 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $70.69 | 2019-2025 | Zilretta, Iovera |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $62.12 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $48.29 | 2022 | |
| Arthrex, INC. | $47.51 | 2019 | |
| Anika Therapeutics, INC. | $45.37 | 2021-2022 | |
| Intellijoint Surgical INC. | $45.03 | 2020-2021 | |
| Bioventus LLC | $44.06 | 2023-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Trice Medical, INC. | $32.93 | 2023 | |
| Treace Medical Concepts, INC. | $29.89 | 2025 | |
| Ethicon US, LLC | $26.41 | 2021 | |
| Gilead Sciences, INC. | $26.15 | 2024 | |
| Wright Medical Technology, INC. | $22.26 | 2019 | |
| Baudax Bio INC. | $20.40 | 2020 | |
| Orthofix Medical, INC. | $19.55 | 2020 | |
| Orthalign INC | $18.32 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.00 | 2019 | |
| Dynasplint Systems INC. | $12.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Oneill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.